Clinical trials sponsored by Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
4
Recruiting trials
10
Conditions studied
Phase breakdown
Phase 4 1Not applicable 3
Conditions studied
| Condition | Trials |
|---|---|
| Migraine | 2 |
| Colorectal cancer | 1 |
| Migraine Disorders | 1 |
| Migraine Headache | 1 |
| Migraine With Aura | 1 |
| Migraine Without Aura | 1 |
| Rectal Cancer | 1 |
| Rectum Neoplasm | 1 |
| Thromboembolism | 1 |
| Ulcerative Colitis | 1 |
Recruiting trials led by Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment
- Migraine Attack Pain Phase Prediction Study
- Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies
Common questions
How many trials is Fundación de Investigación Biomédica - Hospital Universitario de La Princesa recruiting for?
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa is the lead sponsor of 4 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.